- Fourth-quarter revenue of $9.0 million increased 13% sequentially and 60% year-over-year -- One-time impairment charge of $28.3 million reflects changing market valuations -- Announces first quarter 2020 revenue of $12.1 million, a sequential increase of 34% - MINNEAPOLIS, May 14, 2020 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO, OTCQX: VREOF), the science-focused, multi-state cannabis company with active operations in exclusively medical-only markets and licenses in nine states and the Commonwealth of Puerto Rico, today reported...
Read more
Vireo Health Announces Fourth Quarter and Fiscal Year 2019 Financial Results and Pre-Announces First Quarter 2020 Revenue
Vireo Health Announces Formation of Resurgent Biosciences Subsidiary
- Non-plant-touching entity to commercialize Vireo's intellectual property portfolio - MINNEAPOLIS, April 30, 2020 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO, OTCQX: VREOF), the science-focused multi-state...
Read more
What We’re Really Thankful For This Thanksgiving: Our Melting Pot of a Nation
Thanksgiving is many things to many people: a chance to reconnect with family; an opportunity to indulge—okay, sometimes to overindulge—in holiday flavors; and a reminder of this nation’s history as...
Read more
Multi-State Cannabis Company Vireo Health to Begin Trading on the Canadian Securities Exchange Under Ticker Symbol “VREO”
MINNEAPOLIS, MN – March 20, 2019 – Vireo Health International, Inc. (“Vireo” or the "Company”), America’s leading science-focused multi-state cannabis company, is pleased to announce that effective at market open...
Read more
Why Physicians Founded Vireo Health
For Dr. Kyle Kingsley, a trained emergency medical doctor in Minnesota, his perspective on the use of medical cannabis evolved after meeting a Gulf War veteran who had suffered a...
Read more View More >